January 20, 2011 -- We have obtained licenses in India to manufacture and market generic drugs including dietary supplements to markets. We are looking strategic business partners and investors. We are also world leaders in Biosimilars, Vaccines, and Biodrugs and in process of building cGMP disposable manufacturing facility and seeking investment partners. We have developed two novel patents: one in embryonic stem cells for making new generation viral vaccines and the other one in blood brain barrier nanotech delivery. We welcome potential partners.
